Waddell & Reed Financial’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$72.6M Sell
1,613,947
-536,823
-25% -$29.9M 0.15% 178
2020
Q4
$122M Hold
2,150,770
0.26% 109
2020
Q3
$102M Sell
2,150,770
-15,555
-0.7% -$864K 0.25% 113
2020
Q2
$128M Buy
2,166,325
+14
+0% +$779 0.33% 81
2020
Q1
$102M Sell
2,166,311
-23,826
-1% -$1.33M 0.33% 83
2019
Q4
$132M Sell
2,190,137
-989,941
-31% -$59M 0.33% 83
2019
Q3
$191M Buy
3,180,078
+19
+0% +$1.24K 0.49% 48
2019
Q2
$204M Sell
3,180,059
-182,247
-5% -$12.9M 0.51% 43
2019
Q1
$273M Sell
3,362,306
-135,756
-4% -$8.76M 0.68% 33
2018
Q4
$189M Sell
3,498,062
-334,649
-9% -$17.1M 0.54% 43
2018
Q3
$198M Sell
3,832,711
-697,389
-15% -$32.8M 0.44% 56
2018
Q2
$189M Hold
4,530,100
0.44% 56
2018
Q1
$200M Hold
4,530,100
0.45% 57
2017
Q4
$228M Sell
4,530,100
-12,000
-0.3% -$658K 0.51% 49
2017
Q3
$230M Sell
4,542,100
-598,100
-12% -$31.3M 0.51% 52
2017
Q2
$261M Sell
5,140,200
-10,400
-0.2% -$484K 0.58% 44
2017
Q1
$207M Sell
5,150,600
-592,200
-10% -$26.6M 0.44% 66
2016
Q4
$275M Sell
5,742,800
-70,600
-1% -$2.79M 0.6% 45
2016
Q3
$213M Sell
5,813,400
-135,800
-2% -$4.25M 0.44% 63
2016
Q2
$139M Buy
5,949,200
+148,100
+3% +$4.78M 0.29% 94
2016
Q1
$235M Buy
5,801,100
+30,800
+0.5% +$1.25M 0.44% 65
2015
Q4
$357M Hold
5,770,300
0.58% 51
2015
Q3
$233M Buy
5,770,300
+1,000
+0% +$51.8K 0.38% 71
2015
Q2
$332M Buy
5,769,300
+318,900
+6% +$20.3M 0.48% 66
2015
Q1
$347M Hold
5,450,400
0.48% 62
2014
Q4
$337M Sell
5,450,400
-43,700
-0.8% -$2.16M 0.47% 65
2014
Q3
$213M Buy
5,494,100
+130,300
+2% +$4.62M 0.3% 90
2014
Q2
$185M Buy
5,363,800
+48,900
+0.9% +$1.54M 0.27% 98
2014
Q1
$230M Buy
5,314,900
+574,300
+12% +$27.8M 0.35% 77
2013
Q4
$189M Buy
4,740,600
+506,200
+12% +$18M 0.3% 90
2013
Q3
$159M Buy
4,234,400
+357,100
+9% +$10.7M 0.3% 89
2013
Q2
$104M Buy
+3,877,300
New +$82.4M 0.22% 113

Other funds holding IONS